Growth Hormone Secretagogues (GHS)

Growth Hormone Secretagogues work upstream of exogenous HGH — rather than replacing the body’s natural production, these peptides act as agonists at the ghrelin receptor (GHRPs) or the GHRH receptor (GHRH analogs) to trigger a pulsatile, physiologically modulated release of growth hormone from the somatotroph cells of the anterior pituitary.

The research distinction matters. Ipamorelin’s selectivity for GH release without significant cortisol or prolactin elevation makes it a preferred tool for clean somatotropic signaling studies. CJC-1295 with DAC extends the GH pulse duration through its Drug Affinity Complex, enabling sustained receptor engagement useful in longitudinal endocrine research. Tesamorelin, a stabilized GHRH analog, has been studied specifically in the context of visceral adipose tissue reduction and growth hormone deficiency models.

All GHS compounds in this catalog are lyophilized, batch-tested to 99%+ HPLC purity, and shipped from within Canada — eliminating the customs exposure and cold-chain degradation risk that compromises thermally sensitive peptide sequences in international transit.